Elutia (ELUT) Depreciation & Amortization (CF) (2019 - 2026)
Elutia's (ELUT) quarterly Depreciation & Amortization (CF) came in at $330000.0 in Q1 2026, down 61.98% year-on-year from $868000.0 in Q1 2025, and up 11.11% quarter-over-quarter from $297000.0 in Q4 2025.
Elutia (ELUT) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Elutia has disclosed Depreciation & Amortization (CF) across 8 years of filings, most recently posting $330000.0 for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $330000.0, down 61.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (down 34.96% YoY), and the FY2025 annual result was $2.8 million, down 19.3% from the prior year.
- Depreciation & Amortization (CF) came in at $330000.0 for Q1 2026 at Elutia, up from $297000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $954000.0 in Q2 2023 to a low of $297000.0 in Q4 2025.
- The 5-year median for Depreciation & Amortization (CF) is $892000.0 (2025), against an average of $826294.1.
- Peak annual rise in Depreciation & Amortization (CF) reached 3.48% in 2025, while the deepest fall reached 65.59% in 2025.
- Elutia's Depreciation & Amortization (CF) stood at $937000.0 in 2022, then dropped by 4.59% to $894000.0 in 2023, then dropped by 3.47% to $863000.0 in 2024, then plunged by 65.59% to $297000.0 in 2025, then grew by 11.11% to $330000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $330000.0 (Q1 2026), $297000.0 (Q4 2025), and $728000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Elutia | 45.15 Mn | 16.66 Mn | 1.80 Mn | 330,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 330,000.00 |
| Mar 31, 2026 | 330,000.00 |
| Dec 31, 2025 | 297,000.00 |
| Dec 31, 2025 | 297,000.00 |
| Sep 30, 2025 | 728,000.00 |
| Sep 30, 2025 | 728,000.00 |
| Jun 30, 2025 | 892,000.00 |
| Jun 30, 2025 | 892,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | 863,000.00 |
| Dec 31, 2024 | 863,000.00 |
| Sep 30, 2024 | 862,000.00 |
| Sep 30, 2024 | 862,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Jun 30, 2024 | 862,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Dec 31, 2023 | 894,000.00 |
| Dec 31, 2023 | 894,000.00 |